Bevacizumab Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Bevacizumab Side Effects
Did You Have Bevacizumab Side Effect? |
Bevacizumab Side Effects Poll Results | ||||||||
|
Vote Below:
|
Have you experienced Bevacizumab side effects?
|
0%Bevacizumab Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Bevacizumab:
What is Your Question? Ask Community:
Daily Health Videos
Bevacizumab Side Effects reported on Patientsville.com
None reported at this time.Bevacizumab Side Effects reported to FDA
Showing 1-50 of 3955 Next >
Bevacizumab Side Effects Report #5201340-9Health Professional from UNITED STATES reported Bevacizumab side effect on Dec 27, 2006. Female patient, 41 years of age, weighting 145.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebrovascular accident, convulsion. Bevacizumab dosage: unknown. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5203701-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2007. Male patient, weighting 167.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS IV. During the same period patient was treated with COUMADIN, OXYCONTIN, ATIVAN, ZOFRAN, OXYCODONE, DEXMETHASONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5203703-4
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 05, 2007. Male patient, weighting 164.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS IV. During the same period patient was treated with OXYCODONE, COMBIVENT, DEXMETHASONE, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5206174-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 27, 2006. Male patient, 40 years of age, weighting 209.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: brain oedema, cerebral ventricle dilatation, hydrocephalus
. Bevacizumab dosage: 991 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5206956-1
Consumer or non-health professional from UNITED STATES reported Bevacizumab side effect on Jan 08, 2007. Male patient, weighting 190.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, pulmonary embolism . Bevacizumab dosage: 1720 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5208329-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2007. Male patient, weighting 156.5 lb, was diagnosed with mesothelioma
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: impaired work ability, incision site complication, infection , inflammation, lung neoplasm, neoplasm malignant, pneumonia , weight decreased. Bevacizumab dosage: 1084MG Q 21 DAYS IV. During the same period patient was treated with ERLOTINIB, LEVOFLOXACIN, AMBIEN, LIPITOR, METAMUCIL, VITAMIN E, XANAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5208959-X
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 11, 2007. Female patient, 62 years of age, weighting 94.00 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, infection
, lung neoplasm, metastases to lung, pain , pulmonary embolism . Bevacizumab dosage: 446.00 MG Q 2 WEEKS IV. Patient was hospitalized. Patient died on 08/28/2006.Bevacizumab Side Effects Report #5211328-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2007. Male patient, 57 years of age, weighting 190.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5211342-4
Consumer or non-health professional from UNITED STATES reported Bevacizumab side effect on Jan 03, 2007. Female patient, 61 years of age, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: liver function test abnormal, pyrexia. Bevacizumab dosage: 558 MG. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, NEULASTA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5211798-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 16, 2007. Male patient, 49 years of age, weighting 206.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, pneumonia . Bevacizumab dosage: 937 MG Q 14 DAYS IV. During the same period patient was treated with PROLEUKIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5213131-3
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 18, 2007. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with renal cancer metastatic, metastases to lung and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fall
, radius fracture, ulna fracture. Bevacizumab dosage: 740 MG IV X 1. During the same period patient was treated with PROLEUKIN, ZETIA, PROTONIX, SYNTHROID, IBUPROFEN, NORVASC, BACOLFEN. Patient recovered.Bevacizumab Side Effects Report #5213156-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Female patient, weighting 195.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Bevacizumab dosage: 440 MG. During the same period patient was treated with CAMPTOSAR, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5213853-4
Physician from UNITED STATES reported Bevacizumab side effect on Jan 08, 2007. Male patient, 49 years of age, weighting 198.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diverticulitis. Bevacizumab dosage: 1268 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5215801-X
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 08, 2007. Female patient, 54 years of age, weighting 140.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, atelectasis, blood bilirubin increased, cardiac arrest , diarrhoea, dyspnoea, hepatic necrosis, hepatic steatosis, intestinal ischaemia. Bevacizumab dosage: 640 MG, Q3W, INTRAVENOUS. During the same period patient was treated with XELODA, DARVOCET, PHENERGAN, PROPOFOL. Patient was hospitalized. Patient died on 11/30/2006.Bevacizumab Side Effects Report #5215812-4
Physician from UNITED STATES reported Bevacizumab side effect on Jan 02, 2007. Male patient, 38 years of age, was diagnosed with metastatic malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, flatulence, gastrointestinal disorder, metastases to liver, metastases to lymph nodes, metastases to spleen, nausea . Bevacizumab dosage: 10 MG/KG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5216295-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Female patient, 41 years of age, weighting 145.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5218715-4
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 10, 2007. Female patient, 71 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aldolase increased, antinuclear antibody positive, arthritis
, blood glucose increased, blood immunoglobulin g increased, decreased appetite, dyspnoea, glycosylated haemoglobin increased, haemoglobin decreased. Bevacizumab dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, METFORMIN, NPH INSULIN, PROPACET, SENNOSIDE A. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5219068-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2007. Male patient, weighting 191.8 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia
, asthenia, dysarthria, facial palsy, ischaemic cerebral infarction. Bevacizumab dosage: 870 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5220106-7
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 24, 2007. Male patient, weighting 213.8 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coronary arterial stent insertion, creatine phosphokinase decreased, metastases to central nervous system, sinus bradycardia, unresponsive to stimuli. Bevacizumab dosage: 10MG/KG IV Q OTHER WK.. During the same period patient was treated with ASPIRIN, PLAVIX, LISINOPRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5221067-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 08, 2007. Female patient, 45 years of age, weighting 222.7 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. Patient died.
Bevacizumab Side Effects Report #5221070-7
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 10, 2007. Male patient, 40 years of age, weighting 209.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: brain oedema, hydrocephalus
, intraventricular haemorrhage, pneumocephalus. Bevacizumab dosage: 991 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5221869-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 26, 2007. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with renal cancer metastatic, metastases to lung and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fall
, pathological fracture, radius fracture. Bevacizumab dosage: 740 MG IV X 1. During the same period patient was treated with PROLEUKIN, ZETIA, PROTONIX, SYNTHROID, IBUPROFEN, NORVASC, BACOLFEN. Patient recovered.Bevacizumab Side Effects Report #5223436-8
Physician from POLAND reported Bevacizumab side effect on Jan 12, 2007. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, cold agglutinins positive, disease progression, epistaxis. Bevacizumab dosage: 7.5 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5223438-1
Bevacizumab side effect was reported by a Physician from FRANCE on Jan 22, 2007. Female patient, 37 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, subileus. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5224455-8
Physician from UNITED STATES reported Bevacizumab side effect on Jan 17, 2007. Male patient, 49 years of age, weighting 198.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diverticulitis, diverticulum intestinal. Bevacizumab dosage: 1268 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5224744-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2007. Male patient, 72 years of age, weighting 186.0 lb, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chills, dehydration, fatigue, mucosal inflammation, myalgia, nausea , pyrexia, unevaluable event. Bevacizumab dosage: 455 MG X1 IV. During the same period patient was treated with DOCETAXEL, CHEMO, LISINOPRIL, POTASSIUM ACETATE, FERROS GLUCONATE, FUROSEMIDE, GLYBURIDE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5225749-2
Pharmacist from UNITED STATES reported Bevacizumab side effect on Jan 31, 2007. Male patient, 63 years of age, weighting 149.0 lb, was diagnosed with neoplasm malignant, constipation
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , flatulence, haemoptysis, pneumonia , purulence. Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS. During the same period patient was treated with BUBBLE GUM ENEMA, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5225993-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Female patient, 45 years of age, weighting 222.7 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. Patient died on 12/29/2006.
Bevacizumab Side Effects Report #5226026-6
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 23, 2007. Female patient, 66 years of age, weighting 220.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cellulitis
, cellulitis staphylococcal, condition aggravated, haematocrit decreased, haemoglobin decreased, oedema peripheral, pseudomonas infection, purulence, ulcer . Bevacizumab dosage: 1590 MG, Q3W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5227087-0
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Feb 01, 2007. Female patient, 48 years of age, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, varices oesophageal. Bevacizumab dosage: 5MG/KG Q2WEEKS. Patient recovered.
Bevacizumab Side Effects Report #5229515-3
Physician from UNITED STATES reported Bevacizumab side effect on Jan 19, 2007. Male patient, 60 years of age, weighting 225.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abnormal behaviour, computerised tomogram abnormal, deep vein thrombosis
, hydrocephalus , pulmonary embolism . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5230838-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2007. Male patient, 76 years of age, weighting 172.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, fatigue, oral intake reduced, weight decreased. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, RADIATION. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5232076-6
Physician from UNITED STATES reported Bevacizumab side effect on Jan 24, 2007. Female patient, 85 years of age, was diagnosed with detachment of retinal pigment epithelium and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: detachment of retinal pigment epithelium. Bevacizumab dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5232142-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Male patient, 57 years of age, weighting 190.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5232175-9
Health Professional from UNITED STATES reported Bevacizumab side effect on Jan 22, 2007. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, disease progression, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.Bevacizumab Side Effects Report #5232178-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 24, 2007. Female patient, 90 years of age, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: choroidal neovascularisation, detachment of retinal pigment epithelium, haemorrhage. Bevacizumab dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5232395-3
Physician from POLAND reported Bevacizumab side effect on Jan 19, 2007. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, cold agglutinins positive, disease progression, epistaxis. Bevacizumab dosage: 7.5 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5236414-X
Bevacizumab side effect was reported by a Health Professional from ITALY on Jan 30, 2007. Male patient, 59 years of age, was diagnosed with detachment of retinal pigment epithelium and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: condition aggravated, detachment of retinal pigment epithelium, metamorphopsia. Bevacizumab dosage: 1.25 MG, UNK, INTRAVITREAL. Patient recovered.
Bevacizumab Side Effects Report #5239000-0
Physician from UNITED STATES reported Bevacizumab side effect on Feb 02, 2007. Male patient, 69 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: erosive oesophagitis. Bevacizumab dosage: 1395 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5239007-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 30, 2007. Male patient, 63 years of age, weighting 183.0 lb, was diagnosed with gallbladder cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure congestive, pneumonia , respiratory failure. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5239689-6
Physician from UNITED STATES reported Bevacizumab side effect on Feb 06, 2007. Female patient, weighting 132.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, dehydration, haematuria, thrombocytopenia. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5241595-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Male patient, weighting 228.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
, venous thrombosis. Bevacizumab dosage: 518 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5242284-6
Health Professional from UNITED STATES reported Bevacizumab side effect on Feb 16, 2007. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with renal cancer metastatic, metastases to lung and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, fall
, radius fracture. Bevacizumab dosage: 740 MG IV X 1. During the same period patient was treated with PROLEUKIN, ZETIA, PROTONIX, SYNTHROID, IBUPROFEN, NORVASC, BACOLFEN. Patient recovered.Bevacizumab Side Effects Report #5243044-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, weighting 207.2 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Bevacizumab dosage: 940 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5246603-6
Health Professional from UNITED STATES reported Bevacizumab side effect on Feb 22, 2007. Female patient, weighting 141.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, jaundice
, metastases to liver, pain , peritoneal carcinoma. Bevacizumab dosage: 5MG/KG Q 2 WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5247168-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 07, 2007. Male patient, 37 years of age, weighting 174.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebral haemorrhage. Bevacizumab dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5248681-7
Health Professional from UNITED STATES reported Bevacizumab side effect on Feb 26, 2007. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with renal cancer metastatic, metastases to lung and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: fall
, radius fracture. Bevacizumab dosage: 740 MG IV X 1. During the same period patient was treated with PROLEUKIN, ZETIA, PROTONIX, SYNTHROID, IBUPROFEN, NORVASC, BACOLFEN. Patient recovered.Bevacizumab Side Effects Report #5248706-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 09, 2007. Male patient, 69 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal tenderness, erosive oesophagitis, weight decreased. Bevacizumab dosage: 1395 MG Q3W INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DEXAMETHASONE, REGLAN, EMEND, KYTRIL, PHENERGAN, PRILOSEC. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5252893-6
Health Professional from JAPAN reported Bevacizumab side effect on Feb 11, 2007. Male patient, 60 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chills, neutropenia, pyrexia, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DICLOFENAC, REBAMIPIDE, MAGNESIUM OXIDE, NIFEDIPINE, VALSARTAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5252909-7
Bevacizumab side effect was reported by a Physician from FRANCE on Feb 07, 2007. Female patient, 58 years of age, weighting 165.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, disease progression, hypertension, international normalised ratio increased, thrombosis. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, LOVENOX, RABEPRAZOLE, ATACAND, ATENOLOL. Patient was hospitalized. Patient recovered.
Showing 1-50 of 3955 Next >
Advise and Guidance
Nausea and Dealing with drug side effects - part 1